Monopar Therapeutics SEC filings MNPR
Monopar Therapeutics has 536 filings in SEC EDGAR's recent list, going back to Jun 18, 2015. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| 4 | Insider transaction | Nov 4, 2026 | Nov 2, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 20, 2026 | Oct 20, 2026 |
| 4 | Insider transaction | Oct 5, 2026 | Oct 1, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 2, 2026 | Sep 30, 2026 |
| 144 | Notice of proposed sale | Oct 1, 2026 | — |
| 4 | Insider transaction | Sep 28, 2026 | Sep 24, 2026 |
| 144 | Notice of proposed sale | Sep 24, 2026 | — |
| 4/A | Form 4/a | Aug 28, 2026 | Aug 26, 2026 |
| 4/A | Form 4/a | Aug 28, 2026 | Aug 25, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 26, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 26, 2026 |
| 4 | Insider transaction | Aug 27, 2026 | Aug 25, 2026 |
| 144 | Notice of proposed sale | Aug 26, 2026 | — |
| 144 | Notice of proposed sale | Aug 26, 2026 | — |
| 144 | Notice of proposed sale | Aug 25, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2026 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 POS | Form s-8 pos | Jul 22, 2026 | — |
| S-8 | Employee stock plan registration | Jul 22, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 22, 2026 | Jul 22, 2026 |
| 144/A | Filing | Jul 10, 2026 | — |
| 144 | Notice of proposed sale | Jul 7, 2026 | — |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jul 2, 2026 | Jun 30, 2026 |
| 4 | Insider transaction | Jun 30, 2026 | Jun 26, 2026 |
| 3 | Initial insider ownership | Jun 30, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 26, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
May 19, 2026 | May 19, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 19, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 10-K/A | Amended annual report | Apr 1, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2026 | Mar 27, 2026 |
| 10-K | Annual report | Mar 27, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Mar 4, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 2, 2026 | Mar 2, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 6, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Jan 30, 2026 | — |
| 4 | Insider transaction | Jan 30, 2026 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Jan 5, 2026 | Jan 1, 2026 |
| 4 | Insider transaction | Dec 29, 2025 | Dec 26, 2025 |
| 144 | Notice of proposed sale | Dec 19, 2025 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 17, 2025 | Dec 16, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 2, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2025 | Nov 9, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 26, 2025 | Sep 24, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 24, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 24, 2025 | Sep 23, 2025 |
| 424B5 | Prospectus supplement | Sep 24, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2025 | Sep 15, 2025 |
| EFFECT | Filing | Sep 9, 2025 | — |
| CORRESP | Letter to the SEC | Sep 5, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 4, 2025 | — |
| S-3 | Shelf registration | Aug 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| UPLOAD | Letter from the SEC | Jul 25, 2025 | — |
| CORRESP | Letter to the SEC | Jul 22, 2025 | — |
| 4 | Insider transaction | Jul 16, 2025 | Jul 14, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 14, 2025 |
| 4 | Insider transaction | Jul 16, 2025 | Jul 14, 2025 |
| UPLOAD | Letter from the SEC | Jul 16, 2025 | — |
| 144 | Notice of proposed sale | Jul 14, 2025 | — |
| 144 | Notice of proposed sale | Jul 14, 2025 | — |
| 144 | Notice of proposed sale | Jul 14, 2025 | — |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | Jul 2, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 17, 2025 |
| DEFA14A | Additional proxy material | May 23, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | May 12, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 7, 2025 | May 7, 2025 |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Apr 4, 2025 | Apr 2, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 144 | Notice of proposed sale | Apr 2, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 4, 2025 |
| 3 | Initial insider ownership | Mar 6, 2025 | Feb 21, 2025 |
| 4 | Insider transaction | Mar 5, 2025 | Mar 3, 2025 |
| 3 | Initial insider ownership | Mar 5, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 3, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 24, 2025 | Feb 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 7, 2025 | — |
| EFFECT | Filing | Jan 27, 2025 | — |
| 424B3 | Prospectus | Jan 27, 2025 | — |
| CORRESP | Letter to the SEC | Jan 23, 2025 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2025 | — |
| S-3 | Shelf registration | Jan 15, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 8, 2025 | — |
| 4 | Insider transaction | Jan 2, 2025 | Jan 1, 2025 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Dec 23, 2024 | Dec 20, 2024 |
| 424B5 | Prospectus supplement | Dec 23, 2024 | — |
| 424B3 | Prospectus | Dec 18, 2024 | — |
| EFFECT | Filing | Dec 17, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 17, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2024 | Dec 6, 2024 |
| S-3 | Shelf registration | Nov 29, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 8, 2024 | Nov 8, 2024 |
| 10-Q | Quarterly report | Nov 8, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 6, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 31, 2024 | — |
| 4 | Insider transaction | Oct 30, 2024 | Oct 28, 2024 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 30, 2024 | Oct 28, 2024 |
| 424B5 | Prospectus supplement | Oct 29, 2024 | — |
| 424B5 | Prospectus supplement | Oct 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 28, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, New debt, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 23, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2024 | Oct 22, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 15, 2024 | Oct 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 7, 2024 | Oct 7, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 12, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 27, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 21, 2024 | Aug 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 9, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Aug 9, 2024 | Aug 9, 2024 |
| ARS | Annual report to shareholders | Jul 22, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Jul 22, 2024 | Aug 5, 2024 |
| PRE 14A | Preliminary proxy statement | Jul 11, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 9, 2024 | Jul 9, 2024 |
| 4 | Insider transaction | Jul 3, 2024 | Jul 1, 2024 |
| 3 | Initial insider ownership | Jul 3, 2024 | Jul 1, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jun 21, 2024 | Jun 18, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 11, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 10, 2024 | Jun 10, 2024 |
| 4 | Insider transaction | Jun 5, 2024 | Jun 3, 2024 |
| 4 | Insider transaction | May 31, 2024 | May 29, 2024 |
| 4 | Insider transaction | May 30, 2024 | May 28, 2024 |
| 4 | Insider transaction | May 24, 2024 | May 22, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 24, 2024 | May 23, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 16, 2024 | Apr 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 10, 2024 | Apr 10, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Mar 31, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmette, IL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645469
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.